HCA Healthcare, Inc. - Common Stock (HCA)

Historical Holders from Q1 2014 to Q3 2025

Symbol: HCA on NYSE
Type / Class: Equity / Common Stock
Shares outstanding: 247,618,102
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares, excl. options: 136,372,753
Holdings value: $58,103,148,790
% of all portfolios: 0.046%
Number of holders: 1,267
Number of buys: 561
Number of sells: -570
Average buys %: +0%
Average sells %: -0.01%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of HCA Healthcare, Inc. - Common Stock (HCA)

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
BlackRock, Inc.	4.9%		$4,064,772,478		12,133,287		BlackRock, Inc.	31 Mar 2025

Institutional Holders of HCA Healthcare, Inc. - Common Stock (HCA)

Period	Reported Shares, Excl. Options	Value, Excl. Options	Change	Puts Notional Value	Calls Notional Value	Price	Investors
2025 Q3	136,372,753	$58,103,148,790	-$4,115,212,572	$596,685,617	$698,447,317	$426.2	1,267
2025 Q2	146,598,810	$56,127,057,771	-$1,853,153,109	$770,093,009	$655,793,282	$383.1	1,239
2025 Q1	152,192,884	$52,564,357,865	-$2,006,251,000	$535,532,822	$752,595,084	$345.55	1,214
2024 Q4	158,412,925	$47,557,475,465	-$8,742,290	$535,686,386	$599,823,092	$300.15	1,169
2024 Q3	157,628,473	$63,992,248,095	-$2,602,260,628	$706,631,997	$554,487,440	$406.43	1,192
2024 Q2	163,570,360	$52,579,318,347	-$183,070,166	$494,151,451	$439,672,104	$321.28	1,151
2024 Q1	163,721,760	$54,559,435,398	-$1,094,106,832	$413,757,616	$575,139,362	$333.53	1,116
2023 Q4	168,060,091	$45,488,018,617	-$285,213,231	$533,312,304	$376,130,484	$270.68	1,047
2023 Q3	169,154,472	$41,607,918,680	-$1,185,806,069	$466,228,697	$336,531,451	$245.98	989
2023 Q2	173,400,079	$52,556,079,546	-$666,679,406	$401,963,281	$302,357,456	$303.48	1,006
2023 Q1	175,196,823	$46,186,378,435	-$839,492,963	$354,078,568	$297,681,410	$263.68	958
2022 Q4	179,614,269	$43,106,998,862	-$1,135,008,361	$317,802,713	$312,331,314	$239.96	949
2022 Q3	184,870,749	$34,004,075,333	-$752,760,047	$296,228,524	$275,688,198	$183.79	849
2022 Q2	188,490,291	$31,685,644,085	-$1,589,511,131	$139,410,398	$161,277,910	$168.06	854
2022 Q1	198,438,957	$49,759,228,094	-$1,674,801,898	$323,898,234	$244,797,492	$250.62	950
2021 Q4	204,993,837	$52,647,373,530	-$1,558,591,258	$414,211,940	$280,660,264	$256.92	931
2021 Q3	210,742,269	$51,162,204,632	-$2,696,772,377	$370,065,896	$262,094,992	$242.72	870
2021 Q2	221,449,830	$45,771,072,350	-$1,473,962,964	$284,138,784	$211,522,000	$206.74	805
2021 Q1	231,377,874	$43,551,161,088	-$1,184,824,119	$206,300,200	$314,403,000	$188.34	777
2020 Q4	237,137,952	$38,991,278,461	+$223,535,805	$327,140,218	$318,577,026	$164.46	765
2020 Q3	237,038,075	$29,542,477,145	+$374,442,548	$305,953,372	$293,130,564	$124.68	709
2020 Q2	233,611,421	$22,662,190,032	+$114,158,905	$174,871,000	$237,548,000	$97.06	676
2020 Q1	233,576,916	$20,985,688,732	-$500,973,286	$150,715,000	$154,087,000	$89.85	691
2019 Q4	237,576,726	$35,070,820,741	+$69,075,392	$226,559,000	$236,836,000	$147.81	707
2019 Q3	237,425,759	$28,552,762,563	-$390,813,393	$183,878,000	$154,065,000	$120.42	668
2019 Q2	240,503,276	$32,450,213,560	+$200,307,836	$172,249,000	$157,553,000	$135.17	666
2019 Q1	242,859,071	$31,613,110,993	-$72,604,081	$134,802,000	$138,685,000	$130.38	692
2018 Q4	243,226,790	$30,217,039,773	-$151,772,142	$239,219,000	$145,821,000	$124.45	691
2018 Q3	244,050,841	$33,880,893,815	-$405,124,383	$234,973,000	$165,052,000	$139.12	649
2018 Q2	247,244,952	$25,314,355,349	-$453,682,956	$133,194,000	$97,801,000	$102.6	640
2018 Q1	251,241,956	$24,303,990,209	-$605,356,676	$121,173,000	$97,933,000	$97	607
2017 Q4	257,576,538	$22,569,606,948	-$1,125,863,838	$351,314,000	$224,068,000	$87.84	557
2017 Q3	270,067,721	$21,491,862,815	+$432,919	$197,012,000	$179,524,000	$79.59	523
2017 Q2	269,733,979	$23,523,687,954	-$283,225,148	$116,993,000	$276,422,000	$87.2	565
2017 Q1	273,801,978	$24,364,900,598	+$1,921,669,692	$222,828,000	$363,623,000	$88.99	569
2016 Q4	273,996,527	$20,276,620,099	+$125,377,695	$179,022,000	$320,040,000	$74.02	565
2016 Q3	271,673,421	$20,535,113,085	-$512,554,258	$500,866,000	$291,661,000	$75.63	577
2016 Q2	277,691,100	$21,385,005,482	-$925,974,468	$199,601,000	$255,544,000	$77.01	606
2016 Q1	289,930,780	$22,623,817,519	-$261,940,529	$191,901,000	$314,086,000	$78.05	581
2015 Q4	296,382,283	$20,045,696,881	-$1,056,897,195	$360,181,000	$222,695,000	$67.63	575
2015 Q3	309,503,569	$23,938,836,528	-$349,165,270	$393,661,000	$270,336,000	$77.36	630
2015 Q2	313,081,744	$28,402,056,579	-$595,630,068	$730,468,000	$790,837,000	$90.72	651
2015 Q1	321,227,970	$24,164,161,122	+$211,563,363	$310,880,000	$321,326,000	$75.23	591
2014 Q4	318,310,377	$23,361,922,697	-$834,223,912	$375,704,000	$442,986,000	$73.39	540
2014 Q3	329,453,347	$23,233,763,725	+$543,310,103	$257,407,000	$182,282,000	$70.52	499
2014 Q2	323,509,963	$18,244,634,062	-$766,287,989	$203,151,000	$144,619,000	$56.38	437
2014 Q1	337,917,820	$17,736,335,008	+$311,154,994	$96,767,000	$90,511,000	$52.5	399